Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor-Reference-Cited by-同舟云学术

Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor

Published:2018-09-13 Issue:1 Volume:104 Page:e13-e16
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Biondi Andrea,Cario Gunnar,De Lorenzo Paola,Castor Anders,Conter Valentino,Leoni Veronica,Gandemer Virginie,Pieters Rob,Stary Jan,Escherich Gabriele,Campbell Myriam,Attarbaschi Andishe,Li Chi-Kong,Vora Ajay,Bradtke Jutta,Saha Vaskar,Valsecchi Maria Grazia,Schrappe Martin

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of augmented Berlin-Frankfurt-Münster (BFM) and BFM 2000 treatment protocols in children diagnosed with high-risk acute lymphoblastic leukemia;The European Research Journal;2024-09-04

2. Screening and interventional strategies for the late effects and toxicities of hematological malignancy treatments in pediatric survivors;Expert Review of Hematology;2024-06-25

3. CAR-T Therapy Followed by Hematopoietic Stem Cell Transplantation Can Improve Survival in Children Relapsed/Refractory Philadelphia Chromosome–positive B-cell Acute Lymphoblastic Leukemia;Journal of Pediatric Hematology/Oncology;2024-04-23

4. A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens;Hematology;2024-04-06

5. Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia;Cancers;2024-02-21